🔗 Share this article

An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Worries

Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to users injecting products of unknown origin.

Several professionals said the demand for the experimental drug could be linked to the rising cost of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, prosecution or prison.

Service Reaction and Content Elimination

Based on the social media company, the service has removed violative material and prohibited associated keywords and search suggestions. The company stated it was dedicated to keeping the service secure and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays groups with numerous of users, filled with photos of slimming results, positive reviews and step-by-step guides for preparing or administering at home.

Within moments of entering one community, a vendor posted contact information, where most purchases occur. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, messages display black plastic parcels with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When questioned how long a pen should be used, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service stated it actively moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they cannot confirm. Although the research behind retatrutide is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered individuals injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to possibly significant health risks”.